CD47 expression levels may predict evorpacept efficacy in HER2-positive metastatic breast cancer, especially in heavily pretreated patients. Evorpacept combined with zanidatamab shows promising ...

Focusing on the establishment of Sino Biological‘s Center for Bioprocessing (C4B) in Houston, it highlights how the ...

Outcome of chemo-immunotherapy for extensive-stage small-cell lung cancer according to potential clinical trial eligibility: 3-year outcomes from prospective cohort study. Tifcemalimab combined with ...

Alzheimer’s disease (AD) is the most common type of dementia. Brain endothelial cells (BEC), as an important component of the blood-brain barrier, play a significant role in the pathogenesis of AD.

Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...

The global cell line development market size was valued at around USD 5.86 billion in 2024 and is expected to grow to approximately USD 6.44 billion in 2025. The market is projected to reach nearly ...

Nearly every cell in the human body has the ability to detect and respond to viral infection by producing interferons. The timing and magnitude of the interferon response impacts the course of disease ...

Advanced biliary tract cancer (BTC) includes cholangiocarcinoma, gallbladder carcinoma, and ampullary carcinoma. BTC is a rare and aggressive group of cancers, carrying one of the worst prognoses in ...

FREMONT, Calif., May 7, 2025 /PRNewswire/ -- Bionova Scientific, an Asahi Kasei boutique commercial-scale biologics contract development and manufacturing organization (CDMO), today announced it has ...

The time invested in bringing an investigational biological drug to Phase 1 clinical studies can be intense making it increasingly important to harmonize technological innovation with biomanufacturing ...